These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3061858)

  • 1. Increased intestinal growth in the streptozotocin-diabetic rat occurs prior to changes in hormone secretion.
    Schedl HP; Schwartz J; Wilson HD
    Digestion; 1988; 39(3):137-43. PubMed ID: 3061858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characteristics of muscle from diabetic rodent small intestine.
    Nowak TV; Harrington B; Weisbruch JP; Kalbfleisch JH
    Am J Physiol; 1990 May; 258(5 Pt 1):G690-8. PubMed ID: 2185667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced intestinal insulinotropic effect in streptozotocin-diabetic rats.
    Ikeda T; Mokuda O; Kuno S; Tokumori Y; Tominaga M; Mashiba H
    Am J Physiol; 1985 Mar; 248(3 Pt 1):E304-8. PubMed ID: 3883801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal by vanadate of the effect of diabetes on intestinal growth and transport.
    Hajjar JJ; Dobish MP; Tomicic TK
    Diabetes Res; 1989 Mar; 10(3):139-41. PubMed ID: 2805588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of apoptosis is responsible for increased thickness of intestinal mucosa in streptozotocin-induced diabetic rats.
    Noda T; Iwakiri R; Fujimoto K; Yoshida T; Utsumi H; Sakata H; Hisatomi A; Aw TY
    Metabolism; 2001 Mar; 50(3):259-64. PubMed ID: 11230775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of intestinal brush border enzyme activities and oxidative stress in streptozotocin-induced diabetic rats by monocrotophos.
    Vismaya ; Rajini PS
    Chem Biol Interact; 2014 Mar; 211():11-9. PubMed ID: 24440807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of streptozotocin diabetes and insulin replacement on growth hormone in rats.
    Gonzalez C; Jolin T
    J Endocrinol Invest; 1985 Feb; 8(1):7-11. PubMed ID: 3886772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.
    Thulesen J; Hartmann B; Nielsen C; Holst JJ; Poulsen SS
    Gut; 1999 Nov; 45(5):672-8. PubMed ID: 10517902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperplasia of the mesenterial windows precedes that of the small gut in the streptozotocin-diabetic rat.
    Bergström S; Norrby K
    APMIS; 1988 May; 96(5):407-14. PubMed ID: 2967708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphological study of the enteric mucosal epithelium in the streptozotocin-diabetic mouse.
    Ettarh RR; Carr KE
    Life Sci; 1997; 61(18):1851-8. PubMed ID: 9365232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. I. Longitudinal profiles of plasma growth hormone, insulin, and glucose.
    Tannenbaum GS; Colle E; Gurd W; Wanamaker L
    Endocrinology; 1981 Dec; 109(6):1872-9. PubMed ID: 7030716
    [No Abstract]   [Full Text] [Related]  

  • 15. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats.
    Ortiz-Caro J; González C; Jolin T
    Endocrinology; 1984 Dec; 115(6):2227-32. PubMed ID: 6238818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model.
    Tormo MA; Martínez IM; Romero de Tejada A; Gil-Exojo I; Campillo JE
    Exp Clin Endocrinol Diabetes; 2002 May; 110(3):119-23. PubMed ID: 12012271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat.
    Loven DP; Schedl HP; Oberley LW; Wilson HD; Bruch L; Niehaus CL
    Endocrinology; 1982 Sep; 111(3):737-42. PubMed ID: 7049672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.
    Franchimont P; Campistron G; Creuzet MH; Gros J; Luyckx A
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):161-8. PubMed ID: 6372719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired growth hormone secretion in streptozotocin diabetic rats.
    Harrison HE; Robinson TE
    Horm Metab Res; 1980 Oct; 12(10):556-7. PubMed ID: 7439881
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamine and ketone-body metabolism in the gut of streptozotocin-diabetic rats.
    Ardawi MS
    Biochem J; 1988 Jan; 249(2):565-72. PubMed ID: 2893606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.